Provention bio to report second quarter 2022 financial results on august 4, 2022

Red bank, n.j. , july 28, 2022 /prnewswire/ -- provention bio, inc. (nasdaq: prvb), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it will report its second quarter 2022 financial results on thursday, august 4, 2022, before the opening of the u.s. financial markets.
PRVB Ratings Summary
PRVB Quant Ranking